Yi-Kui Xiang, Jie Shen Fok, Indrashis Podder, Muhammed Burak Yücel, Defne Özkoca, Simon Francis Thomsen, Emek Kocatürk
INTRODUCTION: Urticaria, a mast cell-mediated skin disease, manifests as acute or chronic, with the latter divided into spontaneous and inducible types and requires individualized management, including identifying triggers and comorbidities. Antihistamines, particularly the second generation group, form the mainstay of primary treatment plans consisting of dosage adjustments and/or in combination with other treatment modalities depending on underlying disease control. AREAS COVERED: A literature search was conducted using 'antihistamines,' 'urticaria,' 'pharmacogenomics,' 'genomics,' 'biomarkers' and 'treatment response' as key words...
April 23, 2024: Expert Opinion on Pharmacotherapy